Open AccessLaxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection
Author(s) -
Nicole White,
Rafael Mendo-López,
Konstantinos Papamichael,
Christine Cuddemi,
Caitlin Barrett,
Kaitlyn Daugherty,
Nira R. Pollock,
Ciarán P. Kelly,
Carolyn D. Alonso
Publication year - 2019
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz978
Subject(s) - medicine , laxative , clostridium difficile , c difficile , intensive care medicine , clostridioides , microbiology and biotechnology , antibiotics , constipation , biology
To optimize utility of laboratory testing for Clostridiodes difficile infection (CDI), the 2017 Infectious Diseases Society of America-Society for Healthcare Epidemiology of America (IDSA-SHEA) clinical practice guidelines recommend excluding patients from stool testing for C. difficile if they have received laxatives within the preceding 48 hours. Sparse data support this recommendation.